Meningococcal disease

Vieusseux, 1805, Mιmoire sur la maladie qui a regnι a Genκve au printemps de 1805, J Med Chir Pharmacol, 11, 163 Weichselbaum, 1887, Ueber die Aetiologie der akuten Meningitis cerebrospinalis, Fortschr Med, 5, 573 Rosenstein, 2001, Medical progress: Meningococcal disease, New Engl J Med, 344, 1378, 10.1056/NEJM200105033441807 Janda, 2003, Neisseria and Moraxella catarrhalis, 585 Flexner, 1913, The results of serum treatment in thirteen hundred cases of epidemic meningitis, J Exp Med, 17, 553, 10.1084/jem.17.5.553 Healy, 2005, The future of meningococcal vaccines, Pediatr Infect Dis J, 24, 175, 10.1097/01.inf.0000154438.37306.ab Goldacre, 2003, Case fatality rates for meningococcal disease in an English population, 1963–8: database study, BMJ, 327, 596, 10.1136/bmj.327.7415.596 World Health Organization 2010. World Health Organization, Meningococcal meningitis (Fact Sheet) (2010). http://www.who.int/mediacentre/factsheets/fs141/en/print.html. Caugant, 1998, Population genetics and molecular epidemiology of Neisseria meningitidis, APMIS, 106, 505, 10.1111/j.1699-0463.1998.tb01379.x Rosenstein, 1999, The changing epidemiology of meningococcal disease in the United States, 1992–1996, J Infect Dis, 180, 1894, 10.1086/315158 Apicella, 2009, Neisseria Meningitidis Kanegaye, 2001, Lumbar puncture in pediatric bacterial meningitis: defining the time interval for recovery of cerebrospinal fluid pathogens after parenteral antibiotic pretreatment, Pediatrics, 108, 1169 Corless, 2001, Simultaneous detection of Neisseria meningitidis, Haemophilus influenzae, and Streptococcus pneumoniae in suspected cases of meningitis and septicemia using real-time PCR, J Clin Microbiol, 39, 1553, 10.1128/JCM.39.4.1553-1558.2001 Kirsch, 1996, Pathophysiology, treatment and outcome of meningococcemia: a review and recent experience, Pediatr Infect Dis J, 15, 967, 10.1097/00006454-199611000-00009 Wells, 2001, The child with a non-blanching rash: how likely is meningococcal disease?, Arch Dis Child, 85, 218, 10.1136/adc.85.3.218 Nielsen, 2001, Diagnostic assessment of haemorrhagic rash and fever, Arch Dis Child, 85, 160, 10.1136/adc.85.2.160 Pathan, 2003, Pathophysiology of meningococcal meningitis and septicaemia, Arch Dis Child, 88, 601, 10.1136/adc.88.7.601 Welch, 2003, Treatment of meningococcal infection, Arch Dis Child, 88, 608, 10.1136/adc.88.7.608 Goldschneider, 1969, Human immunity to the meningococcus. I. The role of humoral antibodies, J Exp Med, 129, 1307, 10.1084/jem.129.6.1307 Wang, 2000, Antibiotic treatment of children with unsuspected meningococcal disease, Arch Pediatr Adolesc Med, 154, 556, 10.1001/archpedi.154.6.556 De Gans, 2002, Dexamethasone in adults with bacterial meningitis, N Engl J Med., 347, 1549, 10.1056/NEJMoa021334 McIntyre, 1997, Dexamethasone as adjunctive therapy in bacterial meningitis: a meta-analysis of randomized clinical trials since 1988, JAMA, 278, 9925, 10.1001/jama.278.11.925 Rintala, 2000, Protein C substitution in sepsis-associated purpura fulminans, Crit Care Med., 28, 2373, 10.1097/00003246-200007000-00032 Pettenazzo, 2004, Use of protein C concentrate in critical conditions: clinical experience in pediatric patients with sepsis, Minerva Anestesiol, 70, 357 Levi, 2009, Guidelines for the diagnosis and management of disseminated intravascular coagulation, Br J Haematol, 145, 24, 10.1111/j.1365-2141.2009.07600.x Stuart, 2001, Preventing secondary meningococcal disease in health care workers: recommendations of a working group of the PHLS Meningococcus Forum, Commun Dis Public Health, 4, 102 Recommendations of the Advisory Committee on Immunization Practices (ACIP). Prevention and Control of Meningococcal Disease. MMWR 2000;49:1–10. Control and prevention of serogroup C meningococcal disease: evaluation and management of suspected outbreaks: recommendations of the Advisory Committee on Immunization Practices (ACIP). Morb Mortal Wkly Rep 1997;46:13–21. Veeken, 1998, Priority during a meningitis epidemic: vaccination or treatment?, Bull WHO, 76, 135